BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

Bone morphogenetic protein (BMP)2 strongly impacts the differentiation program of myoblast cells by inhibiting myogenesis and inducing osteogenic differentiation. In flip, extracellular matrix (ECM) proteinases, equivalent to urokinase-type plasminogen activator (uPA), can affect the destiny of muscle stem cells by taking part in ECM reorganization. Though each BMP2 and uPA have antagonistic roles in muscular…

Read More